ArticleNutrition research and practice2025
Sex differences of β-carotene effects in azoxymethane/dextran sulfate sodium-induced early colorectal cancer mice.
Article in Nutrition research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
objectivesColorectal cancer (CRC) is a malignancy that occurs in the colon or rectum and ranks as the second leading cause of cancer-related fatalities globally. Numerous epidemiological studies have revealed a distinct difference in CRC between sexes. Specifically, a lower incidence rate and delayed onset in females than in males. β-Carotene (BC), a provitamin A carotenoid, elicits antioxidant effects; however, the potential sex-specific differences in its anti-colon cancer effect are unknown. This study aims to compare the effect of BC on inflammation between sexes in azoxymethane/dextran sulfate sodium (AOM/DSS)-induced early CRC. MATERIALS/
methodsThe AOM/DSS mouse model was established. In early CRC, systemic changes were assessed using the disease activity index (DAI), serum proinflammatory cytokine levels, estradiol, and retinol concentrations. Local changes were evaluated using colon length, tumor counts, proinflammatory cytokines, and estrogen receptor (ER) α expression in the colon.
resultsIn early CRC-induced systemic changes, females had higher DAI scores and lower serum estradiol levels than males. DAI scores were decreased in both sexes, however, serum cytokine levels were reduced by BC supplementation only in females. In the early CRC model, the systemic disease activity in females was higher than that in males. Serum retinol concentrations decreased to a greater extent in female AOM/DSS-induced CRC mice than in their male counterparts. In terms of local changes, the colon was shorter and the ERα expression was increased in females.
conclusionIn early CRC, higher disease activity and specific changes, such as increased DAI scores and reduced serum estradiol in females than in males. BC supplementation could effectively reduce DAI scores and systemic inflammation in both sexes. Notably, serum cytokine levels decreased only in females.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.